WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 11,08 | 11,08 | 2022-09-28 |
| Linfan Zhang | 5,14 | 5,14 | 2022-09-28 |
| Nordnet Pensionsförsäkring | 4,86 | 4,86 | 2022-09-28 |
| Thomas Mellqvist | 1,96 | 1,96 | 2022-09-28 |
| Gunvald Berger | 1,55 | 1,55 | 2022-09-28 |
| Kjell Stenberg | 1,51 | 1,51 | 2022-09-28 |
| Niclas Evertsson | 1,46 | 1,46 | 2022-09-28 |
| Lars-Erik Forsgårdh | 1,31 | 1,31 | 2022-09-28 |
| Christos Tziolas | 0,96 | 0,96 | 2022-09-28 |
| Tommy Andersson | 0,82 | 0,82 | 2022-09-28 |
2022-12-12 Extra bolagsstämma 2022
2023-02-09 Bokslutskommuniké 2022
2023-05-04 Delårsrapport 2023-Q1
2023-06-01 Årsstämma 2022
2023-08-17 Delårsrapport 2023-Q2
2023-11-16 Delårsrapport 2023-Q3